Jordi Xiol

Director/Board Member at

NorthSea Therapeutics BV

Consumer Services

Health Technology

Finance

Profile

Jordi Xiol is currently a Partner at Ysios Capital Partners SGEIC SA since 2019.
He is also a Board Member at NorthSea Therapeutics BV since 2021 and at SpliceBio SL since 2023.
Mr. Xiol completed his undergraduate degree at the University of Barcelona in 2007 and obtained a doctorate from The European Molecular Biology Laboratory.

Jordi Xiol active positions

Companies	Position	Start
Ysios Capital Partners SGEIC SA Ysios Capital Partners SGEIC SA Investment ManagersFinance Ysios Capital invests in companies located across the globe. The firm targets companies operating in the fields of the biotechnology sector. It provides financing for early and growth stage capital requirements.	Private Equity Investor	01/06/2021
SpliceBio SL SpliceBio SL BiotechnologyHealth Technology Engages in research and development in biotechnology	Director/Board Member	01/01/2023
NorthSea Therapeutics BV NorthSea Therapeutics BV BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops novel strategies for the treatment of metabolic, inflammatory and fibrotic diseases	Director/Board Member	01/12/2021

All active positions of Jordi Xiol

Training of Jordi Xiol

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Jordi Xiol's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	5
University of Barcelona University of Barcelona Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
The European Molecular Biology Laboratory The European Molecular Biology Laboratory Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Ysios Capital Partners SGEIC SA Ysios Capital Partners SGEIC SA Investment ManagersFinance Ysios Capital invests in companies located across the globe. The firm targets companies operating in the fields of the biotechnology sector. It provides financing for early and growth stage capital requirements.	Finance
NorthSea Therapeutics BV NorthSea Therapeutics BV BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops novel strategies for the treatment of metabolic, inflammatory and fibrotic diseases	Health Technology
SpliceBio SL SpliceBio SL BiotechnologyHealth Technology Engages in research and development in biotechnology	Health Technology

See company connections